TY - JOUR AU - Lipson, E. J. AU - Forde, P. M. AU - Hammers, H. J. AU - Emens, L. A. AU - Taube, J. M. AU - Topalian, S. L. PY - 2015 DA - 2015// TI - Antagonists of PD-1 and PD-L1 in cancer treatment JO - Semin Oncol VL - 42 UR - https://doi.org/10.1053/j.seminoncol.2015.05.013 DO - 10.1053/j.seminoncol.2015.05.013 ID - Lipson2015 ER - TY - JOUR AU - Brahmer, J. R. AU - Tykodi, S. S. AU - Chow, L. Q. AU - Hwu, W. J. AU - Topalian, S. L. AU - Hwu, P. PY - 2012 DA - 2012// TI - Safety and activity of anti-PD-L1 antibody in patients with advanced cancer JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1200694 DO - 10.1056/NEJMoa1200694 ID - Brahmer2012 ER - TY - JOUR AU - Topalian, S. L. AU - Hodi, F. S. AU - Brahmer, J. R. AU - Gettinger, S. N. AU - Smith, D. C. AU - McDermott, D. F. PY - 2012 DA - 2012// TI - Safety, activity, and immune correlates of anti-PD-1 antibody in cancer JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1200690 DO - 10.1056/NEJMoa1200690 ID - Topalian2012 ER - TY - JOUR AU - Larkin, J. AU - Chiarion-Sileni, V. AU - Gonzalez, R. AU - Grob, J. J. AU - Cowey, C. L. AU - Lao, C. D. PY - 2015 DA - 2015// TI - Combined nivolumab and ipilimumab or monotherapy in untreated melanoma JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1504030 DO - 10.1056/NEJMoa1504030 ID - Larkin2015 ER - TY - JOUR AU - Dong, H. AU - Zhu, G. AU - Tamada, K. AU - Chen, L. PY - 1999 DA - 1999// TI - B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion JO - Nat Med VL - 5 UR - https://doi.org/10.1038/70932 DO - 10.1038/70932 ID - Dong1999 ER - TY - JOUR AU - Freeman, G. J. AU - Long, A. J. AU - Iwai, Y. AU - Bourque, K. AU - Chernova, T. AU - Nishimura, H. PY - 2000 DA - 2000// TI - Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation JO - J Exp Med VL - 192 UR - https://doi.org/10.1084/jem.192.7.1027 DO - 10.1084/jem.192.7.1027 ID - Freeman2000 ER - TY - JOUR AU - Curiel, T. J. AU - Wei, S. AU - Dong, H. AU - Alvarez, X. AU - Cheng, P. AU - Mottram, P. PY - 2003 DA - 2003// TI - Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity JO - Nat Med VL - 9 UR - https://doi.org/10.1038/nm863 DO - 10.1038/nm863 ID - Curiel2003 ER - TY - JOUR AU - Ishida, M. AU - Iwai, Y. AU - Tanaka, Y. AU - Okazaki, T. AU - Freeman, G. J. AU - Minato, N. PY - 2002 DA - 2002// TI - Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues JO - Immunol Lett VL - 84 UR - https://doi.org/10.1016/S0165-2478(02)00142-6 DO - 10.1016/S0165-2478(02)00142-6 ID - Ishida2002 ER - TY - JOUR AU - Rodriguez-Ruiz, M. E. AU - Rodriguez, I. AU - Garasa, S. AU - Barbes, B. AU - Solorzano, J. L. AU - Perez-Gracia, J. L. PY - 2016 DA - 2016// TI - Abscopal effects of radiotherapy are enhanced by combined immunostimulatory mAbs and are dependent on CD8 T cells and crosspriming JO - Cancer Res VL - 76 UR - https://doi.org/10.1158/0008-5472.CAN-16-0549 DO - 10.1158/0008-5472.CAN-16-0549 ID - Rodriguez-Ruiz2016 ER - TY - JOUR AU - Dovedi, S. J. AU - Adlard, A. L. AU - Lipowska-Bhalla, G. AU - McKenna, C. AU - Jones, S. AU - Cheadle, E. J. PY - 2014 DA - 2014// TI - Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/0008-5472.CAN-14-1258 DO - 10.1158/0008-5472.CAN-14-1258 ID - Dovedi2014 ER - TY - JOUR AU - He, J. AU - Hu, Y. AU - Hu, M. AU - Li, B. PY - 2015 DA - 2015// TI - Development of PD-1/PD-L1 pathway in tumor immune microenvironment and treatment for non-small cell lung cancer JO - Sci Rep VL - 5 UR - https://doi.org/10.1038/srep13110 DO - 10.1038/srep13110 ID - He2015 ER - TY - JOUR AU - Blankenberg, F. G. AU - Levashova, Z. AU - Goris, M. G. AU - Hamby, C. V. AU - Backer, M. V. AU - Backer, J. M. PY - 2011 DA - 2011// TI - Targeted systemic radiotherapy with scVEGF/177Lu leads to sustained disruption of the tumor vasculature and intratumoral apoptosis JO - J Nucl Med VL - 52 UR - https://doi.org/10.2967/jnumed.111.091629 DO - 10.2967/jnumed.111.091629 ID - Blankenberg2011 ER - TY - JOUR AU - Bandekar, A. AU - Zhu, C. AU - Jindal, R. AU - Bruchertseifer, F. AU - Morgenstern, A. AU - Sofou, S. PY - 2014 DA - 2014// TI - Anti-prostate-specific membrane antigen liposomes loaded with 225Ac for potential targeted antivascular alpha-particle therapy of cancer JO - J Nucl Med VL - 55 UR - https://doi.org/10.2967/jnumed.113.125476 DO - 10.2967/jnumed.113.125476 ID - Bandekar2014 ER - TY - JOUR AU - Li, L. AU - Wartchow, C. A. AU - Danthi, S. N. AU - Shen, Z. AU - Dechene, N. AU - Pease, J. PY - 2004 DA - 2004// TI - A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles JO - Int J Radiat Oncol Biol Phys VL - 58 UR - https://doi.org/10.1016/j.ijrobp.2003.10.057 DO - 10.1016/j.ijrobp.2003.10.057 ID - Li2004 ER - TY - BOOK AU - Chopra, A. PY - 2004 DA - 2004// TI - 188Re-labeled humanized monoclonal anti-epidermal growth factor receptor antibody PB - Molecular Imaging and Contrast Agent Database (MICAD). Bethesda (MD) CY - Rockville ID - Chopra2004 ER - TY - BOOK AU - Chopra, A. PY - 2004 DA - 2004// TI - 177Lu-labeled humanized monoclonal antibody against human epidermal growth factor receptor 2 PB - Molecular Imaging and Contrast Agent Database (MICAD). Bethesda (MD) CY - Rockville ID - Chopra2004 ER - TY - JOUR AU - Vallabhajosula, S. AU - Nikolopoulou, A. AU - Jhanwar, Y. S. AU - Kaur, G. AU - Tagawa, S. T. AU - Nanus, D. M. PY - 2016 DA - 2016// TI - Radioimmunotherapy of metastatic prostate cancer with (1)(7)(7)Lu-DOTAhuJ591 anti prostate specific membrane antigen specific monoclonal antibody JO - Curr Radiopharm VL - 9 UR - https://doi.org/10.2174/1874471008666150313114005 DO - 10.2174/1874471008666150313114005 ID - Vallabhajosula2016 ER - TY - JOUR AU - Song, H. AU - Shahverdi, K. AU - Huso, D. L. AU - Esaias, C. AU - Fox, J. AU - Liedy, A. PY - 2008 DA - 2008// TI - 213Bi (alpha-emitter)-antibody targeting of breast cancer metastases in the neu-N transgenic mouse model JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-6308 DO - 10.1158/0008-5472.CAN-07-6308 ID - Song2008 ER - TY - JOUR AU - Song, H. AU - Hobbs, R. F. AU - Vajravelu, R. AU - Huso, D. L. AU - Esaias, C. AU - Apostolidis, C. PY - 2009 DA - 2009// TI - Radioimmunotherapy of breast cancer metastases with alpha-particle emitter 225Ac: comparing efficacy with 213Bi and 90Y JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-09-1828 DO - 10.1158/0008-5472.CAN-09-1828 ID - Song2009 ER - TY - JOUR AU - Josefsson, A. AU - Nedrow, J. R. AU - Park, S. AU - Banerjee, S. R. AU - Rittenbach, A. AU - Jammes, F. PY - 2016 DA - 2016// TI - Imaging, biodistribution, and dosimetry of radionuclide-labeled PD-L1 antibody in an immunocompetent mouse model of breast cancer JO - Cancer Res VL - 76 UR - https://doi.org/10.1158/0008-5472.CAN-15-2141 DO - 10.1158/0008-5472.CAN-15-2141 ID - Josefsson2016 ER - TY - JOUR AU - Apostolidis, C. AU - Molinet, R. AU - Rasmussen, G. AU - Morgenstern, A. PY - 2005 DA - 2005// TI - Production of Ac-225 from Th-229 for targeted alpha therapy JO - Anal Chem VL - 77 UR - https://doi.org/10.1021/ac0580114 DO - 10.1021/ac0580114 ID - Apostolidis2005 ER - TY - JOUR AU - Zielinska, B. AU - Apostolidis, C. AU - Bruchertseifer, F. AU - Morgenstern, A. PY - 2007 DA - 2007// TI - An improved method for the production of Ac-225/Bi-213 from Th-229 for targeted alpha therapy JO - Solvent Extr Ion Exch VL - 25 UR - https://doi.org/10.1080/07366290701285108 DO - 10.1080/07366290701285108 ID - Zielinska2007 ER - TY - JOUR AU - Brechbiel, M. W. AU - Gansow, O. A. PY - 1992 DA - 1992// TI - Synthesis of C-functionalized trans-cyclohexyldiethylenetriaminepenta-acetic acids for labeling of monoclonal antibodies with bismuth-212 alpha-particle emitter JO - J Chem Soc Perkin Trans I VL - 1 UR - https://doi.org/10.1039/P19920001173 DO - 10.1039/P19920001173 ID - Brechbiel1992 ER - TY - JOUR AU - Brechbiel, M. W. PY - 2008 DA - 2008// TI - Bifunctional chelates for metal nuclides JO - Q J Nucl Med Mol Imaging VL - 52 ID - Brechbiel2008 ER - TY - JOUR AU - Reilly, R. T. AU - Gottlieb, M. B. C. AU - Ercolini, A. M. AU - Machiels, J. P. H. AU - Kane, C. E. AU - Okoye, F. I. PY - 2000 DA - 2000// TI - HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice JO - Cancer Res VL - 60 ID - Reilly2000 ER - TY - JOUR AU - Reilly, R. T. AU - Machiels, J. P. H. AU - Emens, L. A. AU - Ercolini, A. M. AU - Okoye, F. I. AU - Lei, R. Y. PY - 2001 DA - 2001// TI - The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors JO - Cancer Res VL - 61 ID - Reilly2001 ER - TY - JOUR AU - Nedrow, J. R. AU - Latoche, J. D. AU - Day, K. E. AU - Modi, J. AU - Ganguly, T. AU - Zeng, D. PY - 2016 DA - 2016// TI - Targeting PSMA with a Cu-64 labeled phosphoramidate inhibitor for PET/CT imaging of variant PSMA-expressing xenografts in mouse models of prostate cancer JO - Mol Imaging Biol VL - 18 UR - https://doi.org/10.1007/s11307-015-0908-7 DO - 10.1007/s11307-015-0908-7 ID - Nedrow2016 ER - TY - JOUR AU - Beaino, W. AU - Nedrow, J. R. AU - Anderson, C. J. PY - 2015 DA - 2015// TI - Evaluation of (68)Ga- and (177)Lu-DOTA-PEG4-LLP2A for VLA-4-targeted PET imaging and treatment of metastatic melanoma JO - Mol Pharm VL - 12 UR - https://doi.org/10.1021/mp5006917 DO - 10.1021/mp5006917 ID - Beaino2015 ER - TY - JOUR AU - Back, T. AU - Jacobsson, L. PY - 2010 DA - 2010// TI - The alpha-camera: a quantitative digital autoradiography technique using a charge-coupled device for ex vivo high-resolution bioimaging of alpha-particles JO - J Nucl Med VL - 51 UR - https://doi.org/10.2967/jnumed.110.077578 DO - 10.2967/jnumed.110.077578 ID - Back2010 ER - TY - JOUR AU - Bolch, W. E. AU - Eckerman, K. F. AU - Sgouros, G. AU - Thomas, S. R. PY - 2009 DA - 2009// TI - MIRD pamphlet no. 21: a generalized schema for radiopharmaceutical dosimetry—standardization of nomenclature JO - J Nucl Med VL - 50 UR - https://doi.org/10.2967/jnumed.108.056036 DO - 10.2967/jnumed.108.056036 ID - Bolch2009 ER - TY - JOUR AU - Eckerman, K. AU - Endo, A. PY - 2008 DA - 2008// TI - ICRP publication 107 JO - Ann ICRP VL - 38 UR - https://doi.org/10.1016/j.icrp.2008.10.001 DO - 10.1016/j.icrp.2008.10.001 ID - Eckerman2008 ER - TY - JOUR AU - Hobbs, R. F. AU - Song, H. AU - Huso, D. L. AU - Sundel, M. H. AU - Sgouros, G. PY - 2012 DA - 2012// TI - A nephron-based model of the kidneys for macro-to-micro alpha-particle dosimetry JO - Phys Med Biol VL - 57 UR - https://doi.org/10.1088/0031-9155/57/13/4403 DO - 10.1088/0031-9155/57/13/4403 ID - Hobbs2012 ER - TY - BOOK AU - Bowdler, A. J. PY - 2002 DA - 2002// TI - The complete spleen structure, function and clinical disorders PB - Humana Press Inc CY - Totowa UR - https://doi.org/10.1007/978-1-59259-124-4 DO - 10.1007/978-1-59259-124-4 ID - Bowdler2002 ER - TY - JOUR AU - Dawson, L. A. AU - Kavanagh, B. D. AU - Paulino, A. C. AU - Das, S. K. AU - Miften, M. AU - Li, X. A. PY - 2010 DA - 2010// TI - Radiation-associated kidney injury JO - Int J Radiat Oncol Biol Phys VL - 76 UR - https://doi.org/10.1016/j.ijrobp.2009.02.089 DO - 10.1016/j.ijrobp.2009.02.089 ID - Dawson2010 ER - TY - JOUR AU - Pan, C. C. AU - Kavanagh, B. D. AU - Dawson, L. A. AU - Li, X. A. AU - Das, S. K. AU - Miften, M. PY - 2010 DA - 2010// TI - Radiation-associated liver injury JO - Int J Radiat Oncol Biol Phys VL - 76 UR - https://doi.org/10.1016/j.ijrobp.2009.06.092 DO - 10.1016/j.ijrobp.2009.06.092 ID - Pan2010 ER - TY - JOUR AU - Sgouros, G. PY - 1993 DA - 1993// TI - Bone marrow dosimetry for radioimmunotherapy: theoretical considerations JO - J Nucl Med VL - 34 ID - Sgouros1993 ER - TY - JOUR AU - O’Donoghue, J. A. AU - Baidoo, N. AU - Deland, D. AU - Welt, S. AU - Divgi, C. R. AU - Sgouros, G. PY - 2002 DA - 2002// TI - Hematologic toxicity in radioimmunotherapy: dose-response relationships for I-131 labeled antibody therapy JO - Cancer Biother Radiopharm VL - 17 UR - https://doi.org/10.1089/108497802760363222 DO - 10.1089/108497802760363222 ID - O’Donoghue2002 ER - TY - JOUR AU - Sgouros, G. AU - Graham, M. C. AU - Divgi, C. R. AU - Larson, S. M. AU - Scheinberg, D. A. PY - 1993 DA - 1993// TI - Modeling and dosimetry of monoclonal antibody M195 (anti-CD33) in acute myelogenous leukemia JO - J Nucl Med VL - 34 ID - Sgouros1993 ER - TY - JOUR AU - Scheinberg, D. A. AU - Lovett, D. AU - Divgi, C. R. AU - Graham, M. C. AU - Berman, E. AU - Pentlow, K. PY - 1991 DA - 1991// TI - A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide JO - J Clin Oncol VL - 9 UR - https://doi.org/10.1200/JCO.1991.9.3.478 DO - 10.1200/JCO.1991.9.3.478 ID - Scheinberg1991 ER - TY - BOOK AU - Junghans, R. P. AU - Sgouros, G. AU - Scheinberg, D. A. AU - Chabner, B. A. AU - Longo, D. L. PY - 1996 DA - 1996// TI - Antibody-based immunotherapies of cancer. Cancer chemotherapy and biotherapy PB - Lippincott-Raven Publishers CY - Philadelphia ID - Junghans1996 ER - TY - JOUR AU - Pan, M. H. AU - Gao, D. W. AU - Feng, J. AU - He, J. AU - Seo, Y. AU - Tedesco, J. PY - 2009 DA - 2009// TI - Biodistributions of 177Lu- and 111In-labeled 7E11 antibodies to prostate-specific membrane antigen in xenograft model of prostate cancer and potential use of 111In-7E11 as a pre-therapeutic agent for 177Lu-7E11 radioimmunotherapy JO - Mol Imaging Biol VL - 11 UR - https://doi.org/10.1007/s11307-008-0185-9 DO - 10.1007/s11307-008-0185-9 ID - Pan2009 ER - TY - JOUR AU - Josefsson, A. AU - Zhu, C. AU - Park, S. AU - Abou, D. AU - Song, H. AU - Huso, D. AU - Back, T. AU - Bruchertseifer, F. AU - Morgenstern, A. AU - Bolch, W. E. AU - Sgouros, G. AU - Hobbs, R. F. PY - 2015 DA - 2015// TI - Small scale renal dosimetry for alpha particle radiopharmaceutical therapy of metastatic breast cancer with 225Ac-7.16. 4 JO - Int J Radiat Oncol VL - 2015 UR - https://doi.org/10.1016/j.ijrobp.2015.07.355 DO - 10.1016/j.ijrobp.2015.07.355 ID - Josefsson2015 ER - TY - JOUR AU - Feinendegen, L. E. AU - McClure, J. J. PY - 1997 DA - 1997// TI - Alpha-emitters for medical therapy: workshop of the United States Department of Energy: Denver, Colorado, May 30-31, 1996 JO - Radiat Res VL - 148 UR - https://doi.org/10.2307/3579579 DO - 10.2307/3579579 ID - Feinendegen1997 ER - TY - JOUR AU - Lee, E. AU - Moon, J. W. AU - Wang, X. AU - Kim, C. AU - Li, S. AU - Shin, B. K. PY - 2015 DA - 2015// TI - Genomic copy number signatures uncovered a genetically distinct group from adenocarcinoma and squamous cell carcinoma in non-small cell lung cancer JO - Hum Pathol VL - 46 UR - https://doi.org/10.1016/j.humpath.2015.04.009 DO - 10.1016/j.humpath.2015.04.009 ID - Lee2015 ER - TY - JOUR AU - Chatterjee, S. AU - Lesniak, W. G. AU - Miller, M. S. AU - Lisok, A. AU - Sikorska, E. AU - Wharram, B. PY - 2017 DA - 2017// TI - Rapid PD-L1 detection in tumors with PET using a highly specific peptide JO - Biochem Biophys Res Commun VL - 483 UR - https://doi.org/10.1016/j.bbrc.2016.12.156 DO - 10.1016/j.bbrc.2016.12.156 ID - Chatterjee2017 ER -